Welcome to our dedicated page for Streamline Health Solutions In news (Ticker: STRM), a resource for investors and traders seeking the latest updates and insights on Streamline Health Solutions In stock.
Streamline Health Solutions Inc (STRM) provides technology-driven revenue cycle optimization for healthcare organizations through AI-enhanced platforms and enterprise analytics. This news hub offers investors and industry professionals verified updates on strategic developments impacting the company's financial and operational performance.
Access timely announcements including earnings reports, partnership agreements, product innovations, and leadership changes. Our curated collection focuses on events influencing STRM's market position in healthcare IT, such as SaaS platform enhancements, regulatory compliance updates, and health system client acquisitions.
Key coverage areas span financial results, technology deployments, executive appointments, and industry recognition. All content undergoes strict editorial review to ensure accuracy and relevance for stakeholders tracking revenue cycle management trends.
Bookmark this page for streamlined access to STRM's latest developments in coding automation, clinical documentation improvement, and healthcare data integration solutions. Check regularly for updates reflecting the company's progress in reducing revenue leakage for hospital networks nationwide.
Streamline Health Solutions (NASDAQ: STRM) has secured a contract with a 450-bed health system in Virginia to deploy its eValuator technology, aimed at enhancing revenue integrity and financial performance from patient encounters.
This initiative allows healthcare providers to address coding issues pre-billing, significantly reducing the risk of revenue leakage and denied claims. Streamline Health emphasizes its role in advancing pre-bill technology across hospitals, optimizing coding accuracy before billing and supporting transitions to new payment models. President Ben Stilwill expresses confidence in improving healthcare providers' financial outcomes.
Streamline Health Solutions (NASDAQ: STRM) has announced an expansion in its partnership with a major healthcare system managing over 80 facilities across the U.S. This expansion includes increased utilization of the RevID automated charge reconciliation solution, aimed at improving financial performance. Additionally, the company has surpassed its target, achieving over $17 million in booked SaaS ACV by the end of fiscal 2022. The president of Streamline Health, Ben Stilwill, expressed optimism for continued growth due to their commitment to ensuring healthcare providers are compensated for their services.
Streamline Health Solutions (NASDAQ: STRM) announced a contract with a 350-bed health system in Missouri to implement its eValuator automated pre-bill coding analysis technology. This initiative aims to enhance revenue integrity and financial performance by addressing coding issues before they result in denied claims and revenue leakage. The company combines this technology with expert auditing services to optimize billing accuracy. The President, Ben Stilwill, expressed enthusiasm for supporting the health system in ensuring accurate payments for services rendered.
Streamline Health Solutions (NASDAQ: STRM) has signed a contract with an 850-bed health system in Tennessee to implement its eValuator automated pre-bill coding analysis technology. This initiative aims to enhance revenue integrity and financial performance by addressing coding issues before they lead to revenue leakage and denied claims. Streamline Health combines this technology with expert auditing services to optimize coding accuracy prior to billing. The company emphasizes improving financial performance while aiding the transition to new payment models.
Streamline Health Solutions (STRM) reported a total revenue of $6.2 million for Q3 2022, marking a 13% increase from Q3 2021. SaaS revenue for the quarter stood at $3.2 million, up 14% year-over-year. For the nine months ending October 31, 2022, total revenue rose 60% to $18.1 million. Despite revenue growth, the company experienced a loss from continuing operations of ($3.1) million in Q3 2022, improved from a loss of ($4.4) million in Q3 2021. The company strengthened its balance sheet with an $8.3 million capital raise.
Streamline Health Solutions (Nasdaq: STRM) announced its upcoming financial results for the period ending October 31, 2022, to be released on December 14, 2022, post-market close. A conference call is scheduled for December 15, 2022, at 9:00 AM ET, to discuss the results and provide a corporate update. Participants can join the call through a live webcast or by phone. A replay will be available from December 15 to December 22, 2022. Streamline Health focuses on helping healthcare organizations improve financial performance through integrated solutions and analytics.
Streamline Health Solutions (NASDAQ: STRM) has partnered with a California academic medical center to implement its eValuator technology for automated pre- and post-bill coding analysis. This initiative aims to enhance revenue integrity and improve financial performance by addressing coding issues before they lead to revenue leaks and denied claims. The company is promoting pre-bill technology across hospitals, combining it with expert auditing services for a comprehensive Revenue Integrity Program. This technology is expected to aid in optimizing coding accuracy and transitioning to new payment models.
Streamline Health Solutions has closed a registered direct offering of common stock, raising approximately $8.3 million, with over 30% sourced from insiders. The company has appointed new executives, consolidating its eValuator and Avelead divisions to enhance growth and profitability. Expectations for booked SaaS ACV are projected to reach $17 million by end of fiscal 2022 and $30 million by end of fiscal 2023. The consolidation is anticipated to yield annualized cost savings of approximately $3 million.
Streamline Health Solutions (Nasdaq: STRM) announced on October 25, 2022, a registered direct offering to sell 6,299,989 shares of common stock at $1.32 per share, raising approximately $8.3 million in gross proceeds. The offering is set to close around October 26, 2022, contingent on customary closing conditions. Funds will be used for general corporate purposes. The shares will be offered under a previously filed effective shelf registration statement.
Streamline Health Solutions (NASDAQ: STRM) has secured a contract with a 1,400-bed health system in the Mid-Atlantic to utilize its eValuator automated pre- and post-bill coding analysis technology. This initiative aims to enhance revenue integrity and financial performance from both inpatient and outpatient encounters. The eValuator platform will enable healthcare providers to identify coding issues early, thereby reducing revenue leakage, denied claims, and compliance risks. This strategic partnership aligns with Streamline Health's broader objective to standardize pre-bill technology across hospitals nationwide.